Aureka Releases OpenDDE Open Source Drug Discovery Engine
Aureka announced in a press release the release of Open Drug Discovery Engine (OpenDDE), an open source all atom biomolecular foundation model designed to support AI based therapeutic research. The system serves as a structural reasoning core for modern drug discovery workflows.
OpenDDE models interactions among proteins, nucleic acids, small molecule ligands, and other biomolecular elements through a biomolecular co folding approach. It is designed as a shared structural reasoning layer to connect sequence, structure, and function modeling. The system enables structure prediction and lays groundwork for design, affinity estimation, optimization, and closed loop discovery tasks.
The model includes about 655 million trainable parameters and required roughly 414,000 GPU hours to train, equivalent to about 54 years on one computing unit. Aureka is releasing the training code, inference pipelines, checkpoints, and benchmarks under the Apache 2.0 license to enable independent validation and community collaboration.
Across in silico benchmarks, OpenDDE shows competitive performance in co folding tasks and approaches results reported for IsoDDE level systems while maintaining an open and reproducible framework for the research community.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation
The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.
Read more